Oral Protein Supplements for Nutritional and Quality of Life Improvement After Pancreatic Resection in Elderly Patients

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 7, 2021

Primary Completion Date

July 18, 2022

Study Completion Date

July 18, 2022

Conditions
Pancreatic CancerCholangiocarcinomaIntraductal Papillary Mucinous NeoplasmNeuroendocrine TumorSolid Pseudopapillary Tumor
Interventions
DIETARY_SUPPLEMENT

oral protein supplements

Participants in this group received an oral protein supplement providing 18g of protein per day. The supplement was administered postoperatively and continued throughout the study period. The goal was to assess the impact of protein supplementation on protein intake, nutritional status, quality of life, muscle mass, muscle strength, and 10-meter gait speed. These outcomes were measured at three specific time points: before surgery, at discharge, and during the outpatient visit.

GENETIC

placebo

Participants in this group received a placebo supplement containing carbohydrates instead of protein, which was identical in appearance and taste to the protein supplement to maintain the study's double-blind design. The placebo was administered postoperatively and continued throughout the study period. The aim was to serve as a control to evaluate the effects of the protein supplement on outcomes including nutrient intake, nutritional status, quality of life, muscle mass, muscle strength, and 10-meter gait speed, measured at three key time points: before surgery, at discharge, and during the outpatient visit.

Trial Locations (1)

03722

Department of Surgery, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT06570174 - Oral Protein Supplements for Nutritional and Quality of Life Improvement After Pancreatic Resection in Elderly Patients | Biotech Hunter | Biotech Hunter